CDK4 and breast carcinoma: Indeed, miR-122-5p inhibitors indicated a major effect of miR-122-5p on the regulation of key antiapoptotic proteins Bcl-2 [120,121] and cyclin-dependent kinases (CDK2, CDK4 and CDK6) in drug-resistant breast cancer cells in response to RSV.